Compare Midi Utama Indonesia Tbk. (MIDI) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Midi Utama Indonesia Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Midi Utama Indonesia Tbk. trades at Rp266 (market cap 8.89T, 6.27M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Midi Utama Indonesia Tbk. is far larger — about 85.2× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| MIDI | SCPI | |
|---|---|---|
Market Cap | 8.89T | 104.4B |
Volume | 6.27M | — |
Lot | 62.74K | — |
Turnover | 1.67B | — |
Average Price | 266.81 | — |
Value | 1.67B | — |
Indicative Equilibrium Price | 266 | — |
Indicative Equilibrium Volume | 237 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Midi Utama Indonesia Tbk.
PT Midi Utama Indonesia (the company) was established under its original name of PT Midimart Utama base on notarial deed No.37 of Mr Frans Elsius, S.H, dated on 28 Jun, 2007. The Company’s articles of association has been amended several times, most recently by notarial deed No. 2 of Kamelina, S.H., dated Mar 3, 2010, concerning among others, increase in capital paid up and public offering.
Read more on MIDI →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
